Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effects of Chinese medicine Shansong Yangxin capsule for sinus bradycardia complicated with ventricular premature beats.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: kejiang Cao
• Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital; Third Military Medical University

Criteria

Inclusion Criteria:

• 18 Years to 70 Years old

• Documented sinus bradycardia with average heart rate at 45-59 by 24hours ambulatory EKG

• Ventricular premature beats: >1000 beats/24 hours

Exclusion Criteria:

• Younger than 18 years or older than 75 years

• Symptomatic sinus arrest >3 seconds or high degree atrioventricular block indicated for pacemaker

• Subject suffered from acute coronary syndrome in last three months (Acute myocardial infarction of ST segment elevation and non ST segment elevation, unstable angina

• To be complicated with persistent atrial fibrillation, or paroxysmal atrial fibrillation >5% during 24hrs ambulatory EKG or acute myocarditis

• To be complicated with ventricular fibrillation, torsion type ventricular heartbeat rate, sustained ventricular tachycardia, or non sustained ventricular tachycardia with rapid ventricular rate and hemodynamic disorders

• Sinus heart rate less than 45 beats/minutes and needs to receive the pacemaker or has received pacemaker, or with ICD,CRTP/D